PAPER Wu S, Hu L, Fu Y, Chen Y, Hu Z, Li H, Liu Z
SEARCH RESULTS
329930 RESULTS
PAPER Lo Giudice M, Cocco A, Reggiardo G, Lalli S, Albanese A
Tauro-Urso-Deoxycholic Acid Trials in Amyotrophic Lateral Sclerosis: What is Achieved and What to Expect.
Clin Drug Investig. 2023 Dec;43(12):893-903. Epub 2023 Nov 16 PubMed: 37973672PAPER Salcedo C, Pozo Garcia V, García-Adán B, Ameen AO, Gegelashvili G, Waagepetersen HS, Freude KK, Aldana BI
Increased glucose metabolism and impaired glutamate transport in human astrocytes are potential early triggers of abnormal extracellular glutamate accumulation in hiPSC-derived models of Alzheimer's disease.
J Neurochem. 2023 Dec 8; PubMed: 38063257PAPER Macías M, Acha B, Corroza J, Urdánoz-Casado A, Roldan M, Robles M, Sánchez-Ruiz de Gordoa J, Erro ME, Jericó I, Blanco-Luquin I, Mendioroz M
Liquid Biopsy in Alzheimer's Disease Patients Reveals Epigenetic Changes in the PRLHR Gene.
Cells. 2023 Nov 22;12(23) PubMed: 38067107PAPER Jin Y, Li X, Yuan Q, Huang X, Zhang D
Visualization analysis of exercise intervention on Alzheimer disease based on bibliometrics: Trends, hotspots and topics.
Medicine (Baltimore). 2023 Dec 8;102(49):e36347. PubMed: 38065914PAPER Hou Y, Dong L, Cao L
Saxagliptin reduces the injury of Alzheimer's disease cell model by down-regulating the expression of miR-483-5p.
Cell Mol Biol (Noisy-le-grand). 2023 Nov 30;69(12):188-193. PubMed: 38063096PAPER Kitada T, Ardah MT, Haque ME
History of Parkinson's Disease-Associated Gene, Parkin: Research over a Quarter Century in Quest of Finding the Physiological Substrate.
Int J Mol Sci. 2023 Nov 24;24(23) PubMed: 38069057PAPER Yamasaki R
Connexins Control Glial Inflammation in Various Neurological Diseases.
Int J Mol Sci. 2023 Nov 28;24(23) PubMed: 38069203PAPER Belosludtseva NV, Matveeva LA, Belosludtsev KN
Mitochondrial Dyshomeostasis as an Early Hallmark and a Therapeutic Target in Amyotrophic Lateral Sclerosis.
Int J Mol Sci. 2023 Nov 27;24(23) PubMed: 38069154PAPER Stella R, Bonadio RS, Cagnin S, Andreotti R, Massimino ML, Bertoli A, Peggion C
Secreted Metabolome of ALS-Related hSOD1(G93A) Primary Cultures of Myocytes and Implications for Myogenesis.
Cells. 2023 Nov 30;12(23) PubMed: 38067180PAPER Titus C, Hoque MT, Bendayan R
PPAR agonists for the treatment of neuroinflammatory diseases.
Trends Pharmacol Sci. 2024 Jan;45(1):9-23. Epub 2023 Dec 7 PubMed: 38065777PAPER Chen BH, Lin ZY, Zeng XX, Jiang YH, Geng F
LRP4-related signalling pathways and their regulatory role in neurological diseases.
Brain Res. 2024 Feb 15;1825:148705. Epub 2023 Dec 6 PubMed: 38065285PAPER Gholamalishahi S, Hosseini SA, Ettorre E, Mannocci A, Okechukwu CE, Keshavarz MJ, La Torre G
The Association between Levels of Physical Activity and Lifestyle, Life Expectancy, and Quality of Life in Patients with Alzheimer's Disease.
J Clin Med. 2023 Nov 26;12(23) PubMed: 38068378PAPER Reilich P, Schöberl F, Hiebeler M, Tonon M, Ludolph AC, Senel M
Myelitis as a side effect of tofersen therapy in SOD1-associated ALS.
J Neurol. 2024 Apr;271(4):2114-2118. Epub 2023 Dec 9 PubMed: 38066205PAPER Santos J, Pallarès I, Ventura S
A glimpse into the structural properties of α-synuclein oligomers.
Biofactors. 2023 Dec 8; PubMed: 38063360Current Filters
No filters selected